Parenteral Drugs (India) informs about disclosure

23 Feb 2023 Evaluate
Parenteral Drugs (India) has informed that Parenteral Drugs (India) (The CD) that CIRP has been initiated in respect of the CD under the provisions of Insolvency and Bankruptcy Code, 2016 ('Code') by order CP IB (IB)/690/(MB)2020 of National Company Law Tribunal ('NCLT') Mumbai Bench no I dated 09/02/23. The Certified True copy of the Order received by IRP on 10/02/2023, Friday late evening, thus CIRP initiated from 11/02/2023 by the IRP As per section 17 of the Code, the powers of the Board of Parenteral Drugs (India) Limited (The CD) stands suspended and such powers shall be vested with Interim Resolution Professional, Kairav Anil Trivedi - Interim Resolution Professional, having IP Registration no. IBBI/IPA-002/IP-N00728/2018-2019/12332, E-mail: kairavtrivedi2002@yahoo.co.in, Mobile No.: 9987330793 having office at 413-414, Shramjeevan B5, Opp. Lodha, New Cuffe Parade, Wadala (E), Mumbai - 400037 appointed as the Interim Resolution Professional vide the above order.

The above information is a part of company’s filings submitted to BSE.

Parenteral Drugs Share Price

3.39 0.00 (0.00%)
21-Aug-2023 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.